• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性与医疗服务提供者对激素避孕风险因素评估的一致性。

Agreement between women's and providers' assessment of hormonal contraceptive risk factors.

作者信息

Shotorbani Solmaz, Miller Leslie, Blough David K, Gardner Jacqueline

机构信息

Department of Pharmacy, The University of Washington, Box 357630, Seattle, WA 98195, USA.

出版信息

Contraception. 2006 May;73(5):501-6. doi: 10.1016/j.contraception.2005.12.001. Epub 2006 Mar 20.

DOI:10.1016/j.contraception.2005.12.001
PMID:16627034
Abstract

OBJECTIVE

To measure agreement between women's self-administered risk factor questionnaire and their providers' evaluation of their medical eligibility for hormonal contraceptive use.

METHODS

This was an anonymous cross-sectional study. Participants were women 15-45 years old who completed a 20-item self-administered questionnaire. Women were recruited from six public health family planning clinics in the Seattle Metropolitan area. A matching medical evaluation questionnaire was completed concurrently by each participant's health care provider. Using provider evaluation as the "gold standard" against which we compared self-reported medical history, we calculated participant-provider agreement with point estimates and 95% confidence interval (CI).

RESULTS

Of 399 participant and provider pairs, participant-provider agreement was obtained for 392 participant pairs. The majority of the participants (90.3%) were 15-30 years old and 77.7% had used a hormonal contraceptive method for more than 1 year. The estimated proportion of the overall agreement was 96% (95% CI, 0.92-0.98). Women were more likely to report severe headaches (12.4% vs. 3.3%), possible pregnancy (7.3% vs. 3.5%) and smoking (6.2% vs. 2.1%) than providers, but less likely to report smoking more than 15 cigarettes per day (2.6% vs. 9.2%) and irregular menses (6.5% vs. 9.9%).

CONCLUSION

Overall, a high proportion of the women in this study completed our medical history questionnaire in concordance with their health care providers' same-day medical evaluation. Agreement on critical medical eligibility criteria such as hypertension was well above 90%. For criteria on which there was disagreement, women were more likely to identify contraindications than were their providers.

摘要

目的

衡量女性自行填写的风险因素问卷与医疗服务提供者对其使用激素避孕药物的医学适宜性评估之间的一致性。

方法

这是一项匿名横断面研究。参与者为15至45岁的女性,她们完成了一份包含20个条目的自填问卷。这些女性是从西雅图都会区的六家公共卫生计划生育诊所招募而来的。每位参与者的医疗服务提供者同时完成一份匹配的医学评估问卷。以医疗服务提供者的评估作为“金标准”,并据此比较自我报告的病史,我们计算了参与者与医疗服务提供者之间的一致性,并给出点估计值和95%置信区间(CI)。

结果

在399对参与者与医疗服务提供者中,有392对参与者达成了一致。大多数参与者(90.3%)年龄在15至30岁之间,77.7%的人使用激素避孕方法超过1年。总体一致性的估计比例为96%(95%CI,0.92 - 0.98)。与医疗服务提供者相比,女性更有可能报告严重头痛(12.4%对3.3%)、可能怀孕(7.3%对3.5%)和吸烟(6.2%对2.1%),但报告每天吸烟超过15支(2.6%对9.2%)和月经不规律(6.5%对9.9%)的可能性较小。

结论

总体而言,本研究中的大多数女性在填写病史问卷时与医疗服务提供者当天的医学评估结果一致。在诸如高血压等关键医学适宜性标准方面的一致性远高于90%。对于存在分歧的标准,女性比其医疗服务提供者更有可能识别出禁忌证。

相似文献

1
Agreement between women's and providers' assessment of hormonal contraceptive risk factors.女性与医疗服务提供者对激素避孕风险因素评估的一致性。
Contraception. 2006 May;73(5):501-6. doi: 10.1016/j.contraception.2005.12.001. Epub 2006 Mar 20.
2
Public and private providers' involvement in improving their patients' contraceptive use.公立和私立医疗机构参与提高其患者的避孕措施使用率。
Contraception. 2008 Jul;78(1):42-51. doi: 10.1016/j.contraception.2008.03.009. Epub 2008 May 29.
3
A comparison of women's, providers' and ultrasound assessments of pregnancy duration among termination of pregnancy clients in South Africa.南非堕胎女性、医护人员及超声检查对堕胎女性妊娠时长评估的比较
BJOG. 2007 May;114(5):569-75. doi: 10.1111/j.1471-0528.2007.01293.x.
4
Consistency between most important reasons for using contraception and current method used: the influence of health care providers.使用避孕措施的最重要原因与当前所采用方法之间的一致性:医疗保健提供者的影响。
Contraception. 2006 Apr;73(4):399-403. doi: 10.1016/j.contraception.2005.10.007. Epub 2006 Jan 17.
5
Validation of an internet questionnaire for risk assessment in preconception care.孕前保健风险评估网络问卷的验证
Public Health Genomics. 2010;13(2):89-94. doi: 10.1159/000228980. Epub 2009 Jul 17.
6
Same-sex attraction disclosure to health care providers among New York City men who have sex with men: implications for HIV testing approaches.纽约市男男性行为者向医疗服务提供者披露同性吸引情况:对艾滋病毒检测方法的影响
Arch Intern Med. 2008 Jul 14;168(13):1458-64. doi: 10.1001/archinte.168.13.1458.
7
(Mis)understanding in patient-health care provider communication about total knee replacement.患者与医疗服务提供者在全膝关节置换术沟通方面的(误)解
Arthritis Rheum. 2009 Jan 15;61(1):100-7. doi: 10.1002/art.24371.
8
Jamaican and Barbadian health care providers' knowledge, attitudes and practices regarding emergency contraceptive pills.牙买加和巴巴多斯医疗保健提供者对紧急避孕药的知识、态度和做法。
Int Fam Plan Perspect. 2007 Dec;33(4):160-7. doi: 10.1363/ifpp.33.160.07.
9
Does a competitive voucher program for adolescents improve the quality of reproductive health care? A simulated patient study in Nicaragua.针对青少年的竞争性代金券计划能否提高生殖健康护理质量?尼加拉瓜的一项模拟患者研究。
BMC Public Health. 2006 Aug 7;6:204. doi: 10.1186/1471-2458-6-204.
10
Conformity with current guidelines on oral contraceptive prescribing for breastfeeding women: a New Mexico survey.
Contraception. 2006 Nov;74(5):389-93. doi: 10.1016/j.contraception.2006.06.007. Epub 2006 Aug 17.

引用本文的文献

1
Reclassifying contraceptives as over-the-counter medicines to improve access.将避孕药重新归类为非处方药以改善获取途径。
Bull World Health Organ. 2022 Aug 1;100(8):503-510. doi: 10.2471/BLT.21.287561. Epub 2022 Jun 22.
2
Physicians' Opinion Regarding Extended Access to Hormonal Contraception in Switzerland.瑞士医生关于扩大激素避孕药物获取途径的意见。
Pharmacy (Basel). 2021 Nov 12;9(4):184. doi: 10.3390/pharmacy9040184.
3
Adolescents' and Young Adults' Ability to Self-Screen for Contraindications to Hormonal Contraception and the Role of Chronic Illness.
青少年和青年自我筛查激素避孕禁忌的能力以及慢性病的作用。
J Adolesc Health. 2021 Oct;69(4):566-573. doi: 10.1016/j.jadohealth.2021.04.032. Epub 2021 Jun 4.
4
Contraindications to Hormonal Contraception Among Postpartum Women in Texas.德克萨斯州产后妇女使用激素避孕的禁忌证。
Obstet Gynecol. 2021 May 1;137(5):907-915. doi: 10.1097/AOG.0000000000004347.
5
Prescription Requirements and Patient Autonomy: Considering an Over-the-Counter Default.处方要求与患者自主权:考虑非处方药默认选项。
Hastings Cent Rep. 2020 Nov;50(6):15-26. doi: 10.1002/hast.1195.
6
Extended Access to Hormonal Contraception in Pharmacies: A Survey among Swiss Pharmacists.瑞士药店激素避孕药物的扩大获取情况:对瑞士药剂师的一项调查
Pharmacy (Basel). 2020 Nov 10;8(4):210. doi: 10.3390/pharmacy8040210.
7
Patient and pharmacist perspectives on pharmacist-prescribed contraception: A systematic review.患者和药剂师对药剂师开具避孕药具的看法:系统评价。
Contraception. 2021 Feb;103(2):66-74. doi: 10.1016/j.contraception.2020.10.012. Epub 2020 Oct 29.
8
Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist Perspective.长效、患者自控、无需手术的避孕方法:药剂师视角下的安悦环综述
Pharmacy (Basel). 2020 Aug 28;8(3):156. doi: 10.3390/pharmacy8030156.
9
Bills as Band-Aids: Hopes and Challenges of Expanding Pharmacists' Prescriptive Authority to Include Contraceptives.作为权宜之计的法案:扩大药剂师开具避孕药具处方权的希望与挑战
HEC Forum. 2019 Dec;31(4):295-304. doi: 10.1007/s10730-019-09380-w.
10
Should oral contraceptive pills be available without a prescription? A systematic review of over-the-counter and pharmacy access availability.口服避孕药应无需处方即可购买吗?非处方及药房购药可得性的系统评价。
BMJ Glob Health. 2019 Jun 25;4(3):e001402. doi: 10.1136/bmjgh-2019-001402. eCollection 2019.